Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Taiho Pharmaceutical
Taiho Pharmaceutical
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
CP Wire
Fri, 07/13/18 - 11:55 am
AB928
Arcus Biosciences
Taiho Pharmaceutical
oncology
Asia
Japan
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
Fri, 07/13/18 - 09:29 am
AB928
Arcus Biosciences
Taiho Pharmaceutical
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
CP Wire
Thu, 06/21/18 - 10:13 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
Thu, 06/21/18 - 09:53 am
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Taiho Pharmaceutical Announces Termination of Phase III Clinical Trial of the Angiogenesis Inhibitor TSU-68 (orantinib) in Patients with Hepatocellular Carcinoma
Pipeline Review
Sat, 08/2/14 - 10:48 am
TSU-68
Taiho Pharmaceutical
hepatocellular carcinoma